Published in Gene Therapy Weekly, April 28th, 2005
Study 1: Numerous gene mutations in retinitis pigmentosa challenge gene therapy design.
According to a study from the Peoples Republic of China, "retinitis pigmentosa (RP) is a group of inherited progressive retinal diseases affecting about 1 in 3500 people worldwide. So far, there is no prevention or cure, with permanent visual loss or even blindness the ultimate consequence usually after midlife. The genetics of RP are complex."
"It can be sporadic, autosomal dominant, autosomal recessive, or X-linked. Thirty-two genes are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-04-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.